Likewise, increased levels of CD33+ pSTAT3+ myeloid‐derived suppressor cells (MDSC), IL-17+ lymphocytes, and IL-10 mRNA expression may all contribute to the progression of BPH to PCa in PCa patients [133]. This evidence concerns the gene IL17A and benign prostatic hyperplasia.